Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SOTERA HEALTH COMPANY

(SHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sotera Health Q3 Adjusted Earnings, Net Revenue Increase; 2021 Guidance Range Narrowed

11/10/2021 | 07:22am EST


ę MT Newswires 2021
All news about SOTERA HEALTH COMPANY
01/11Sotera Health Sees 2021 Revenue at High End of Guidance Range
MT
01/11SOTERA HEALTH : Chairman and CEO Presents at 40th Annual J.P. Morgan Healthcare Virtual Co..
PU
01/11SOTERA HEALTH CO : Results of Operations and Financial Condition (form 8-K)
AQ
01/11Sotera Health Company Updates Revenue Guidance for the Full-Year 2021
CI
01/11Sotera Health Chairman and CEO Presents at 40th Annual J.P. Morgan Healthcare Virtual C..
AQ
01/03Sotera Health to Present at the Virtualá40th Annual J.P. Morgan Healthcare Conference
AQ
2021Clinical Laserthermia Systems AB Enters into Agreement with Two Additional Suppliers of..
CI
2021SOTERA HEALTH CO Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2021Sotera Health Company Mulls M&A
CI
2021Sotera Health Reports Third-Quarter and Year-to-Date 2021 Results - Form 8-K
PU
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2021 929 M - -
Net income 2021 116 M - -
Net Debt 2021 1 694 M - -
P/E ratio 2021 52,6x
Yield 2021 -
Capitalization 6 156 M 6 156 M -
EV / Sales 2021 8,45x
EV / Sales 2022 7,46x
Nbr of Employees 3 000
Free-Float -
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | SHC | US83601L1026 | MarketScreener
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 21,76 $
Average target price 31,75 $
Spread / Average Target 45,9%
EPS Revisions
Managers and Directors
Michael B. Petras Chairman & Chief Executive Officer
Scott J. Leffler Chief Financial Officer & Treasurer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director